Xuechi Lin
P.R. China
Changsha, 410219, China
Changsha, 410219, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Introduction of exogenous wild‑type p53 mediates the regulation of oncoprotein 18/stathmin signaling via nuclear factor‑κB in non‑small cell lung cancer NCI‑H1299 cells.
Journal: Oncology reports
Published: March 01, 2018
RNAi targeting STMN alleviates the resistance to taxol and collectively contributes to down regulate the malignancy of NSCLC cells in vitro and in vivo.
Journal: Cell biology and toxicology
Published: February 16, 2017
Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin.
Journal: Oncology reports
Published: August 15, 2016
The Cdc2/Cdk1 inhibitor, purvalanol A, enhances the cytotoxic effects of taxol through Op18/stathmin in non-small cell lung cancer cells in vitro.
Journal: International journal of molecular medicine
Published: August 01, 2016
Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice.
Journal: Basic & clinical pharmacology & toxicology
Published: March 19, 2016
Regulation of Oncoprotein 18/Stathmin Signaling by ERK Concerns the Resistance to Taxol in Nonsmall Cell Lung Cancer Cells.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: February 17, 2016
Op18/stathmin is involved in the resistance of taxol among different epithelial carcinoma cell lines.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: November 08, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026